Pancreatic Cancer Research

ResearcherUniversity of California, IrvineActive in the last 2 years

Aimee L Edinger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4277-4584; OpenAlex author ID A5048283029; NIH RePORTER profile ID 1869097. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
1
Labs led
1
Collaborators
13
Papers, trials and grants by year

2024: 1 grant · 2025: none · 2026: 1 paper

Papers 1

  1. Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2026.09.027↗

Grants 1

  1. Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance R01CA247556↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher J. Halbrook · 1 shared paper, 2026 · strength 0.20
  2. Alexander Muir · 1 shared paper, 2026 · strength 0.20
  3. Jennifer Brooke Valerin · 1 shared paper, 2026 · strength 0.20
  4. Chantal Allgöwer · 1 shared paper, 2026 · strength 0.20
  5. Austin D. Silva · 1 shared paper, 2026 · strength 0.20
  6. Tim Eiseler · 1 shared paper, 2026 · strength 0.20
  7. Rima Singh · 1 shared paper, 2026 · strength 0.20
  8. Kevin Christian Montecillo Gulay · 1 shared paper, 2026 · strength 0.20
  9. Alica K. Michels · 1 shared paper, 2026 · strength 0.20
  10. Alexander Kleger · 1 shared paper, 2026 · strength 0.20
  11. Thomas Theodor Werner Seufferlein · 1 shared paper, 2026 · strength 0.20
  12. David Kuang-Fu Chang · 1 shared paper, 2026 · strength 0.20
  13. Hervé Tiriac · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.